Literature DB >> 19804433

In or out? Income losses in health state valuations: a review.

Carl Tilling1, Marieke Krol, Aki Tsuchiya, John Brazier, Werner Brouwer.   

Abstract

BACKGROUND: In 1996 the Washington Panel controversially recommended valuing productivity costs (PC) in terms of quality-adjusted life years. The Panel's assumption that respondents in health state valuation (HSV) exercises take income losses into account could not be countered since there was no evidence regarding what people consider in HSV exercises. If they do consider income losses and if this changes HSVs, then all economic evaluations that have included PC in the numerator may have double-counted these costs. Alternatively, if respondents do not consider income losses then all past economic evaluations that have not included PC in the numerator have failed to account for sizeable societal costs.
OBJECTIVES: Through a review we aim to recapture the debate surrounding the appropriate method for including PC in health economic evaluations, to identify empirical evidence addressing the assumptions of the Panel, and recommend a future research agenda.
METHODS: Through a review we identify, outline, and critically appraise the existing empirical studies that attempt to address whether respondents include income effects in HSV exercises. RESULTS AND
CONCLUSION: Seven empirical studies were identified. Overall, it seems that not explicitly mentioning the inclusion of income will induce a minority of respondents to include these effects and this appears not to influence results. More empirical work is needed, using generic instruments, larger samples, and using the interview method of administration.

Entities:  

Mesh:

Year:  2009        PMID: 19804433     DOI: 10.1111/j.1524-4733.2009.00614.x

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  13 in total

1.  Does the EQ-5D reflect lost earnings?

Authors:  Carl Tilling; Marieke Krol; Aki Tsuchiya; John Brazier; Job van Exel; Werner Brouwer
Journal:  Pharmacoeconomics       Date:  2012-01       Impact factor: 4.981

Review 2.  Productivity costs in economic evaluations: past, present, future.

Authors:  Marieke Krol; Werner Brouwer; Frans Rutten
Journal:  Pharmacoeconomics       Date:  2013-07       Impact factor: 4.981

3.  Considering productivity loss in cost-effectiveness analysis: a new approach.

Authors:  Afschin Gandjour
Journal:  Eur J Health Econ       Date:  2014-11

Review 4.  The Valuation of Informal Care in Cost-of-Illness Studies: A Systematic Review.

Authors:  Juan Oliva-Moreno; Marta Trapero-Bertran; Luz Maria Peña-Longobardo; Raúl Del Pozo-Rubio
Journal:  Pharmacoeconomics       Date:  2017-03       Impact factor: 4.981

5.  Cost-effectiveness of spinal manipulative therapy, supervised exercise, and home exercise for older adults with chronic neck pain.

Authors:  Brent Leininger; Christine McDonough; Roni Evans; Tor Tosteson; Anna N A Tosteson; Gert Bronfort
Journal:  Spine J       Date:  2016-06-23       Impact factor: 4.166

6.  Cost-Effectiveness of Open Versus Endoscopic Carpal Tunnel Release.

Authors:  James I Barnes; Gabrielle Paci; Thompson Zhuang; Laurence C Baker; Steven M Asch; Robin N Kamal
Journal:  J Bone Joint Surg Am       Date:  2021-02-17       Impact factor: 6.558

7.  Do the Washington Panel recommendations hold for Europe: investigating the relation between quality of life versus work-status, absenteeism and presenteeism.

Authors:  Saskia Knies; Annelies Boonen; Johan L Severens
Journal:  Cost Eff Resour Alloc       Date:  2014-11-24

Review 8.  A noticeable difference? Productivity costs related to paid and unpaid work in economic evaluations on expensive drugs.

Authors:  Marieke Krol; Jocé Papenburg; Siok Swan Tan; Werner Brouwer; Leona Hakkaart
Journal:  Eur J Health Econ       Date:  2015-04-16

9.  Association between work time loss and quality of life in patients with Herpes Zoster: a pooled analysis of the MASTER studies.

Authors:  Emmanouil Rampakakis; Melissa Stutz; Kosuke Kawai; Tsen-Fang Tsai; Hee Jin Cheong; Jittima Dhitavat; Alejandro Ortiz-Covarrubias; Miguel Cashat-Cruz; Homero Monsanto; Kelly D Johnson; John S Sampalis; Camilo J Acosta
Journal:  Health Qual Life Outcomes       Date:  2017-01-18       Impact factor: 3.186

10.  A cross-sectional survey of work and income loss consideration among patients with herpes zoster when completing a quality of life questionnaire.

Authors:  Kelly D Johnson; Susan K Brenneman; Chrisann Newransky; Seth Sheffler-Collins; Laura K Becker; Angela Belland; Camilo J Acosta
Journal:  BMC Health Serv Res       Date:  2018-08-25       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.